MATTHEW INSLEY: Open Payments
NPI 1346758679 · DEPEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,860 in 98 payments from 16 companies in 2025. Trend: 2023 $2,013 · 2024 $3,079 · 2025 $1,860
Food & beverage: $1,660Education: $200
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 18 | $239 |
| ABBVIE INC. | 16 | $227 |
| Lilly USA, LLC | 5 | $211 |
| Novartis Pharmaceuticals Corporation | 26 | $204 |
| Janssen Biotech, Inc. | 4 | $189 |
| GENZYME CORPORATION | 4 | $179 |
| UCB, Inc. | 9 | $148 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $132 |
| PFIZER INC. | 3 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, Bimzelx, EBGLYSS, CIBINQO.
Industry payments across NY — which companies pay providers there.
